1. Noiph KD, Peritoneal Dialysis. In Textbook of Kidney (Vol 2) Edited by Brenner BM, and Rector F.C, Philadelphia, 1991;2229-2336
2. Leeney DJ, Gandhi VC, and Daugrrdas JT. Capd Peritonitis. In: Handbook of Dialysis. Edited by Daugirdas JT, anding TS. Boston/Toronto, Little Brown 1988;252-273.
3. Khanna R, Nolph KD, Oraeopulas DG. Peritonitis and exit-site infection. In: The Essentials of Peritoneal Dialysis. Kluwer Academic Publishers, Dortecht, Boston London 1993;76-88
4. Brown AL, Stephenson JR, Baker LRj.J. ve ark. Epidemiology of CAPD associated Peritonitis caused by coagulase-negative Staphylococci: Comparison of strains isolated from hands, abdominal Tenckhoff catheter exit-site and peritoneal fluid. Mephrology Dialysis and Transplantation, Vol 1991;643-648.
5. Lane T, Chandran P.Ten-years experience with exit-site
infections. Nephron 1990;55:220-221
6. Keane WF, Everett ED. Fine RN, ve ark. CAPD Peritonitis treatment recommendations: 1989 Update. Peritoneal Dialysis
International. Vol 1989;9:247-256.
7. Struijik DG, Van Ketal RJ, Kredeit RT, ve ark. Viral
Peritonis in a continuons ambulatory peritoneal dialysis
patient. Nephron 1986;44:384.
8. Bint AJ, Finch RG, Gökal R. ve ark. Diagnosis and management of peritonitis in ontinuos ambulatory peritoneal
dialysis. The Lancet, April 1987;11:845:848.
9. Glancey GR, Cameron JS. Ogg CS. Peritoneal drainage an important element in host defence against staphylococcal peritonitis in patients on CAPD. Nephrology Dialysis and
Transplantation. Vol 1992;7:627-631.
10. Blevins RD. ve ark. Pharmacokinetiks of Vancomycin in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrobial Agents Chemotherapy. 1984;25:600.
11. Bunke CM, ve ark. Vancomycin kinetics during continuous ambulatory peritonel dialysis. Clin Pharmacol Ther. 1983;34:631.
12. Krothapalli RK, Senekjian HO. Efficacy of intravenous vancomycin in the treatment of gram ( + ) peritonitis in long trem peritoneal dialysis. Am J Med 1983;75:345347.
13. Wilcox NH, Geary I, Spencer RC. In-Vitro activity of imipenam in comparison with cefuroxime and ciprofloxacine against coagulase (-) staphylocacci in peritoneal dialysis fluid.
J. Antimicrobial Chemother 1992;49:55.
14. Dreyden MS, Wing AJ, Phillips I. Low dose intraperitoneal ciprofloxacine for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J
Antimicrobial Chemother. 1991; 131-139.
15. Jancnect R. CAPD pertonitis and fluoroquinolons. A Review,
perit Dial Int 1991;48-58.
16. Bennett-Jones DN, Russel G.I. Barrett AA. comparison between oral ciprofloxacine and intra-peritoneal vancomicin and gentamicin in treatment of CAPD peritonitis. J Antimicrobial Chemother 1990;73-76.
17. Al-Wali W, Baillod R, Brumfitt W, ve ark. Differing
prognostic significance of reinfection and relaps in CAPD peritonitis. Nephrol Dial Transplant 1992;133-136.
18. Bazzato G, Landini S, Coli U, ve ark. A new techkhic of CAPD: Double bag system for freedom to the patient and significant reduction of peritonitis. Clinical Nephrol 1980;6:251-254.
Thank you for copying data from http://www.arastirmax.com
